373 related articles for article (PubMed ID: 28683787)
1. The effect and safety of postmenopausal hormone therapy and selective estrogen receptor modulators on kidney outcomes in women: a protocol for systematic review and meta-analysis.
Dumanski SM; Ramesh S; James MT; Metcalfe A; Nerenberg K; Seely EW; Robertson HL; Ahmed SB
Syst Rev; 2017 Jul; 6(1):134. PubMed ID: 28683787
[TBL] [Abstract][Full Text] [Related]
2. The effect of hormone therapy on all-cause and cardiovascular mortality in women with chronic kidney disease: protocol for a systematic review and meta-analysis.
Ramesh S; Mann MC; Holroyd-Leduc JM; Wilton SB; James MT; Seely EW; Ahmed SB
Syst Rev; 2015 Apr; 4():44. PubMed ID: 25874808
[TBL] [Abstract][Full Text] [Related]
3. Hormone therapy and clinical and surrogate cardiovascular endpoints in women with chronic kidney disease: a systematic review and meta-analysis.
Ramesh S; Mann MC; Holroyd-Leduc JM; Wilton SB; James MT; Seely EW; Ahmed SB
Menopause; 2016 Sep; 23(9):1028-37. PubMed ID: 27433866
[TBL] [Abstract][Full Text] [Related]
4. Current and evolving approaches to individualizing estrogen receptor-based therapy for menopausal women.
Santen RJ; Kagan R; Altomare CJ; Komm B; Mirkin S; Taylor HS
J Clin Endocrinol Metab; 2014 Mar; 99(3):733-47. PubMed ID: 24423357
[TBL] [Abstract][Full Text] [Related]
5. Testosterone for peri- and postmenopausal women.
Somboonporn W; Davis S; Seif MW; Bell R
Cochrane Database Syst Rev; 2005 Oct; (4):CD004509. PubMed ID: 16235365
[TBL] [Abstract][Full Text] [Related]
6. Menopause and Chronic Kidney Disease.
Ahmed SB
Semin Nephrol; 2017 Jul; 37(4):404-411. PubMed ID: 28711080
[TBL] [Abstract][Full Text] [Related]
7. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis.
Rovinski D; Ramos RB; Fighera TM; Casanova GK; Spritzer PM
Thromb Res; 2018 Aug; 168():83-95. PubMed ID: 29936403
[TBL] [Abstract][Full Text] [Related]
8. Emerging selective estrogen receptor modulators: special focus on effects on coronary heart disease in postmenopausal women.
Vogelvang TE; van der Mooren MJ; Mijatovic V; Kenemans P
Drugs; 2006; 66(2):191-221. PubMed ID: 16451093
[TBL] [Abstract][Full Text] [Related]
9. Preventing osteoporosis in symptomatic postmenopausal women.
Gallagher JC; Levine JP
Menopause; 2011 Jan; 18(1):109-18. PubMed ID: 20661164
[TBL] [Abstract][Full Text] [Related]
10. Association Between Hormone Therapy and Muscle Mass in Postmenopausal Women: A Systematic Review and Meta-analysis.
Javed AA; Mayhew AJ; Shea AK; Raina P
JAMA Netw Open; 2019 Aug; 2(8):e1910154. PubMed ID: 31461147
[TBL] [Abstract][Full Text] [Related]
11. Effect of hormone replacement therapies and selective estrogen receptor modulators in postmenopausal women with uterine leiomyomas: a literature review.
Ang WC; Farrell E; Vollenhoven B
Climacteric; 2001 Dec; 4(4):284-92. PubMed ID: 11770184
[TBL] [Abstract][Full Text] [Related]
12. Tissue-selective agents: selective estrogen receptor modulators and the tissue-selective estrogen complex.
Pickar JH; Mirkin S
Menopause Int; 2010 Sep; 16(3):121-8. PubMed ID: 20956688
[TBL] [Abstract][Full Text] [Related]
13. Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the U.S. Preventive Services Task Force.
Miller J; Chan BK; Nelson HD
Ann Intern Med; 2002 May; 136(9):680-90. PubMed ID: 11992304
[TBL] [Abstract][Full Text] [Related]
14. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
Pickar JH; Komm BS
Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836
[TBL] [Abstract][Full Text] [Related]
15. Tissue-selective estrogen complexes for postmenopausal women.
Mirkin S; Komm BS
Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
[TBL] [Abstract][Full Text] [Related]
16. The management of menopause in women with a history of endometriosis: a systematic review.
Gemmell LC; Webster KE; Kirtley S; Vincent K; Zondervan KT; Becker CM
Hum Reprod Update; 2017 Jul; 23(4):481-500. PubMed ID: 28498913
[TBL] [Abstract][Full Text] [Related]
17. Hormone therapy and selective estrogen receptor modulators for prevention of coronary heart disease in postmenopausal women estrogen replacement from the cardiologist's perspective.
Mobasseri S; Liebson PR; Klein LW
Cardiol Rev; 2004; 12(6):287-98. PubMed ID: 15476565
[TBL] [Abstract][Full Text] [Related]
18. Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes.
Smith CL; Santen RJ; Komm B; Mirkin S
Breast Cancer Res; 2014 Jun; 16(3):212. PubMed ID: 25928299
[TBL] [Abstract][Full Text] [Related]
19. Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide.
Palacios S; Currie H; Mikkola TS; Dragon E
Maturitas; 2015 Apr; 80(4):435-40. PubMed ID: 25684082
[TBL] [Abstract][Full Text] [Related]
20. The benefits and risks of menopause hormone therapy for the cardiovascular system in postmenopausal women: a systematic review and meta-analysis.
Gu Y; Han F; Xue M; Wang M; Huang Y
BMC Womens Health; 2024 Jan; 24(1):60. PubMed ID: 38263123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
